Welcome!

News Feed Item

Vital Art and Science Announces License Agreement with Genentech for Its mVT® Service

Vital Art and Science, LLC today announced that it has signed a license agreement with Genentech, a member of the Roche Group, for the use of Vital Art and Science’s mVT® App service in Genentech’s ophthalmology clinical studies. Under the terms of the agreement, Genentech intends to use the App service to enhance patient experience, improve the effectiveness of patient‘s interactions with health care providers and apply the data collected through the App service to improve patient care and clinical trial design.

The mVT® App is currently being used in Genentech’s Phase II LADDER study (NCT02510794) investigating the sustained delivery of LUCENTIS® (ranibizumab injection) via Genentech’s Port Delivery System, in patients with wet age-related macular degeneration (AMD). Patients will be testing their vision using the mVT® Service during their in-clinic appointment and at home (remote vision monitoring).

The agreement builds on the prior collaboration between Genentech and Vital Art and Science, under which Genentech used the mVT® Service as part of its PIVOT Study (Patient-centric Innovative Vision Home Testing).

“This agreement is the successful continuation of an ongoing collaboration between the teams at Vital Art and Science and Genentech," said Mike Bartlett, President and CEO, Vital Art and Science. "We believe that Genentech, a leader in ophthalmic drug development, is a strong partner for the mVT® Service that will drive more retina specialists and other ophthalmic drug companies to adopt as the next industry standard for vision monitoring in between office assessments.”

About the mVT® Service

The mVT® Service is currently commercially available to retina specialists for patients with maculopathy, including dry and wet age-related macular degeneration, diabetic retinopathy, diabetic macular edema, macular pucker, macular hole, retinal vein occlusion/branch retinal vein occlusion, and more. The mVT® App is available on both iOS and select Android devices and detects both vision worsening and improvement. Patients can test their vision as often as they wish, but are recommended to do so at least twice a week. The testing procedure is very user-friendly; four shapes are displayed on the screen and the patient chooses the shape that looks different. The test is untimed, has no fixed distance, and includes test-retest variability to reduce the number of false positives. There are three types of patients seen by retina specialists who may benefit from home vision monitoring:

1. The patient who is diagnosed early and has not yet started treatment, but is considered high risk. Such patients may benefit from the mVT® Service because the vision monitoring results and alerts are shared with the physician before the patient's next appointment. Consequently, the mVT® Service acts as a safety net that can alert the physician as soon as their patient’s vision has worsened by greater than +0.2 LogMAR from baseline.

2. Patients receiving treatment in at least one eye. The benefit of monitoring such patients during treatment is that the physician is able to better understand if the patient is responding to the selected anti-VEGF injection. In addition, the physician is able to monitor the patient’s other eye.

3. Patients in the treat-and-extend phase. The mVT® Service again acts as a safety net and notifies the physician whenever the patient’s vision has worsened to an extent greater or equal to +0.2LogMAR. Early detection can lead to earlier physician assessments and treatment.

Retina Specialists and clinics who are interested in providing home vision monitoring to their patients can go to their website to register and sign up to be a prescriber.

About VAS

The team at Vital Art and Science, LLC (VAS) is composed of researchers, entrepreneurs, retina specialists and engineers who all believe “monitoring vision”’ goes beyond the amsler grid, which is why they have engineered and developed the mVT® Service – the first and only FDA cleared vision app available on both the Apple and Android App Stores. Their goal is to reduce vision blindness by actively monitoring the patient’s home vision test results and alerting the patient’s mVT® prescriber of any significant vision function change. VAS is committed to bridging the gap between retina specialists and patients by providing the mVT® Service as a safety net to detect changes in vision function. VAS is known for the mVT® App that displays four shapes; however, the team is actively developing more vision tests that would aid and compliment the current FDA cleared shape discrimination test.

For more information visit www.myvisiontrack.com.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
What's the role of an IT self-service portal when you get to continuous delivery and Infrastructure as Code? This general session showed how to create the continuous delivery culture and eight accelerators for leading the change. Don Demcsak is a DevOps and Cloud Native Modernization Principal for Dell EMC based out of New Jersey. He is a former, long time, Microsoft Most Valuable Professional, specializing in building and architecting Application Delivery Pipelines for hybrid legacy, and cloud ...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
21st International Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Me...
"Tintri focuses on the Ops side of the DevOps, which basically is pushing more and more of the accessibility of the infrastructure to the developers and trying to get behind the scenes," explained Dhiraj Sehgal of Tintri in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We do one of the best file systems in the world. We learned how to deal with Big Data many years ago and we implemented this knowledge into our software," explained Jakub Ratajczak, Business Development Manager at MooseFS, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"Our strategy is to focus on the hyperscale providers - AWS, Azure, and Google. Over the last year we saw that a lot of developers need to learn how to do their job in the cloud and we see this DevOps movement that we are catering to with our content," stated Alessandro Fasan, Head of Global Sales at Cloud Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business - from apparel to energy - is being rewritten by software. From planning to development to management to security, CA creates software that fuels transformation for companies in the applic...
SYS-CON Events announced today that TMC has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo and Big Data at Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Global buyers rely on TMC’s content-driven marketplaces to make purchase decisions and navigate markets. Learn how we can help you reach your marketing goals.
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
You know you need the cloud, but you’re hesitant to simply dump everything at Amazon since you know that not all workloads are suitable for cloud. You know that you want the kind of ease of use and scalability that you get with public cloud, but your applications are architected in a way that makes the public cloud a non-starter. You’re looking at private cloud solutions based on hyperconverged infrastructure, but you’re concerned with the limits inherent in those technologies.
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
"MobiDev is a Ukraine-based software development company. We do mobile development, and we're specialists in that. But we do full stack software development for entrepreneurs, for emerging companies, and for enterprise ventures," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Managing mission-critical SAP systems and landscapes has never been easy. Add public cloud with its myriad of powerful cloud native services and this may not change any time soon. Public cloud offers exciting new possibilities for enterprise workloads. But to make use of these possibilities and capabilities, IT teams need to re-think everything they have done before. Otherwise, they will just end up using public cloud as a hosting platform for their workloads, aka known as “lift and shift.”